Par Drugs & Chemical Share Price Today | Stock Price & Par Drugs & Chemical Share Screener

Track the current stock price of Par Drugs & Chemical with an interactive chart. Analyse PAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Par Drugs & Chemical stock quote in one place.

The quote of ₹168.25 sits between the 52-week low of ₹78.58 and the 52-week high of ₹168.25, and the latest session moved 19.67% from the previous close.

Screen Par Drugs & Chemical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PAR shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE04LG01015.

Classification

Identifiers and Leadership

Screen PAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹129, up from ₹119 in 2025.

Latest statistics put total assets at ₹129 and shareholder funds at ₹112.

Screen Par Drugs & Chemical income statement and profit fundamentals. Analyze PAR quarterly results. Par Drugs & Chemical reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹112 and net profit was ₹15, equal to earnings per unit of ₹11.80, at an operating margin of 17%.

In that period expenses were ₹89, interest cost ₹0 and tax ₹5. The next period listed, 2026-March, shows revenue of ₹108 and net profit of ₹13.

Screen PAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹16, and net cash flow was an inflow of ₹14.

Over the same period, investing activities used ₹2 and financing activities provided ₹0.

See Par Drugs & Chemical shareholding pattern with promoter, FII, and DII holdings. Check Par Drugs & Chemical promoter holding and ownership changes for PAR on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 73.41%, foreign institutions 0.00%, domestic institutions 0.00% and the public 19.97%, spread across 13,222 shareholders.

The shareholder count was 13,222 in 2026-Mar, compared with 12,782 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Par Drugs & Chemical. Par Drugs & Chemical dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

See which indices include Par Drugs & Chemical stock. Check PAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Par Drugs & Chemical corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Par Drugs & Chemical stock events that may affect PAR share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 8, 2026, with a record date of August 8, 2026.

It is followed by Quarterly Result Announcement dated May 14, 2026 and Quarterly Result Announcement dated February 10, 2026.

Screen PAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen PAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated October 3, 2026 and October 2, 2026.

Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 11 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.